BioPharma Pharma & Biopharma Manufacturing

HaemaLogiX and Lonza Collaborate to Manufacture KappaMab

Lonza to manufacture drug substance for clinical supply of HaemaLogiX's lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facil...

 January 28, 2022 | News

Beijing Handian Pharamceutical Held an Expert Seminar About TCM Global Application In Beijing

he seminar first discussed the main reason causes the traditional Chinese medicine hardly used in other countries, which including the complex and rich eff...

 January 27, 2022 | News

Partnership with RoosterBio to advance scalable and continuous exosomes manufacturing

Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable viral production, announces today a strategic...

 January 21, 2022 | News

Vetter's new clinical manufacturing site now officially authorized

Important milestone reached for the new site Additional filling capacities for early-stage clinical development First customer audits already completed...

 January 20, 2022 | News

WuXi Biologics completes the first GMP inspection in 2022

WuXi Biologics  a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by&n...

 January 18, 2022 | News

Piramal Pharma Solutions Strengthens North American Capabilities

The Pharma Solutions (PPS) division of Piramal Enterprises Limited, a leading research, development and contract manufacturing (CDMO) organization, today...

 January 14, 2022 | News

China Based Gracell Biotechnologies Unveils Innovation Center in U.S.

As a pivotal part of Gracell's global strategy, the company is fully committed to expanding its operations in the U.S. to enhance and diversify its in-hous...

 January 13, 2022 | News

Nuance Pharma acquires Sino Health

Nuance Pharma ("Nuance"or the "Company"), a specialty care focused biopharma with late late-stage clinical programs and existing commercial operations, tod...

 January 07, 2022 | News

Calyxt Announces Pilot BioFactory™ Production System Now Operational

"I am proud of the effort our team and suppliers made to achieve this milestone on schedule, as it marks an important step in the scaling of our production...

 January 07, 2022 | News

Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

Under this agreement, ProBioGen develops a scalable process and granted Imvaq® a license to use ProBioGen's AGE1.CR.pIX cell line for the man...

 January 07, 2022 | News

Ascletis Expands Ritonavir Oral Tablet Production

Ritonavir oral tablet annual production capacity has been expanded to 100 million tablets and can be further rapidly expanded based on market demand - ASC...

 January 03, 2022 | News

Biosyngen to commercialize immune cell therapeutics in China

The inauguration ceremony of Biosyngen Pte. Ltd., ("Biosyngen") joint projects and Biosyngen biological production base was held in China-Singapore&nb...

 December 29, 2021 | News

WuXi Biologics, ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody

Within the partnership, ImmuneOncia will have access to WuXi Biologics' integrated services in cell line development, cell culture development, biologics m...

 December 28, 2021 | News

Novavax and SK bioscience Expand Manufacturing Agreement

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

 December 24, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close